| Primary |
| Drug Use For Unknown Indication |
25.5% |
| Insomnia |
16.4% |
| Psychotic Disorder |
9.1% |
| Depression |
7.3% |
| Schizophrenia |
7.3% |
| Mania |
5.5% |
| Hepatitis C |
3.6% |
| Restless Legs Syndrome |
3.6% |
| Agitation |
1.8% |
| Antisocial Behaviour |
1.8% |
| Bipolar Disorder |
1.8% |
| Epilepsy |
1.8% |
| Hiccups |
1.8% |
| Mental Disorder |
1.8% |
| Paranoia |
1.8% |
| Schizoaffective Disorder |
1.8% |
| Schizophrenia, Paranoid Type |
1.8% |
| Self-medication |
1.8% |
| Sleep Disorder |
1.8% |
| Tension |
1.8% |
|
| Weight Increased |
17.2% |
| Catatonia |
6.9% |
| Completed Suicide |
6.9% |
| Hallucination, Auditory |
6.9% |
| Priapism |
6.9% |
| Victim Of Sexual Abuse |
6.9% |
| Adverse Event |
3.4% |
| Agranulocytosis |
3.4% |
| Blindness Transient |
3.4% |
| Blood Alkaline Phosphatase Increased |
3.4% |
| Cardiac Disorder |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Feeling Abnormal |
3.4% |
| Granulocytopenia |
3.4% |
| Leukopenia |
3.4% |
| Neonatal Disorder |
3.4% |
| Nervousness |
3.4% |
| Neuroleptic Malignant Syndrome |
3.4% |
| Oesophageal Atresia |
3.4% |
| Parkinsonism |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
21.2% |
| Drug Use For Unknown Indication |
16.6% |
| Affective Disorder |
14.7% |
| Depression |
8.5% |
| Bipolar Disorder |
6.2% |
| Schizophrenia |
4.2% |
| Mental Disorder |
3.3% |
| Attention Deficit/hyperactivity Disorder |
2.9% |
| Sleep Disorder |
2.9% |
| Colorectal Cancer |
2.6% |
| Prophylaxis |
2.3% |
| Convulsion |
2.0% |
| Hepatitis C |
2.0% |
| Aggression |
1.6% |
| Hiccups |
1.6% |
| Ill-defined Disorder |
1.6% |
| Insomnia |
1.6% |
| Psychotic Disorder |
1.6% |
| Abnormal Behaviour |
1.3% |
| Agitation |
1.3% |
|
| Completed Suicide |
16.9% |
| Weight Increased |
12.7% |
| Treatment Noncompliance |
9.9% |
| Drug Hypersensitivity |
5.6% |
| Drug Toxicity |
4.2% |
| Nervousness |
4.2% |
| Ovarian Cyst |
4.2% |
| Pancreatitis |
4.2% |
| Somnolence |
4.2% |
| Swollen Tongue |
4.2% |
| Toxicity To Various Agents |
4.2% |
| Accidental Overdose |
2.8% |
| Aggression |
2.8% |
| Myocardial Infarction |
2.8% |
| Schizophrenia |
2.8% |
| Skin Discolouration |
2.8% |
| Tardive Dyskinesia |
2.8% |
| Thinking Abnormal |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Vascular Resistance Systemic Increased |
2.8% |
|
| Concomitant |
| Depression |
16.7% |
| Bipolar Disorder |
16.0% |
| Schizophrenia |
11.1% |
| Anxiety |
8.5% |
| Sleep Disorder |
6.6% |
| Product Used For Unknown Indication |
5.7% |
| Drug Use For Unknown Indication |
5.0% |
| Pain |
4.3% |
| Insomnia |
4.2% |
| Hypertension |
3.2% |
| Multiple Myeloma |
2.9% |
| Agitation |
2.6% |
| Psychotic Disorder |
2.5% |
| Schizoaffective Disorder |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Mental Disorder |
1.8% |
| Affective Disorder |
1.4% |
| Hiccups |
1.4% |
| Smoking Cessation Therapy |
1.2% |
| Hallucination, Auditory |
1.2% |
|
| Type 2 Diabetes Mellitus |
37.8% |
| Weight Increased |
14.2% |
| Pancreatitis |
9.1% |
| Tardive Dyskinesia |
7.0% |
| Diabetes Mellitus |
5.0% |
| Type 1 Diabetes Mellitus |
3.8% |
| Obesity |
2.8% |
| Urinary Tract Infection |
2.4% |
| Diabetic Coma |
2.1% |
| Vomiting |
2.1% |
| Diabetic Ketoacidosis |
1.9% |
| Suicide Attempt |
1.5% |
| Wound Drainage |
1.5% |
| Suicidal Behaviour |
1.4% |
| Vision Blurred |
1.3% |
| Weight Decreased |
1.3% |
| Ketoacidosis |
1.2% |
| Diabetic Neuropathy |
1.1% |
| Neuropathy Peripheral |
1.1% |
| Suicidal Ideation |
1.1% |
|
| Interacting |
| Product Used For Unknown Indication |
47.8% |
| Mental Disorder |
16.3% |
| Smoking Cessation Therapy |
14.1% |
| Blood Cholesterol Increased |
3.3% |
| Hypothyroidism |
3.3% |
| Lipids Increased |
3.3% |
| Type 1 Diabetes Mellitus |
3.3% |
| Anger |
2.2% |
| Insomnia |
2.2% |
| Analgesic Therapy |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Schizophrenia |
1.1% |
| Tobacco Abuse |
1.1% |
|
| Paranoia |
42.1% |
| Tobacco Withdrawal Symptoms |
15.8% |
| Pollakiuria |
10.5% |
| Agranulocytosis |
5.3% |
| Road Traffic Accident |
5.3% |
| Somnolence |
5.3% |
| Speech Disorder |
5.3% |
| Stress |
5.3% |
| Weight Increased |
5.3% |
|
